PE-22-28 (10mg)

10 mg

We’ve named this remarkable peptide Lucidus, from the Latin for “clear” and “bright,” capturing its extraordinary ability to illuminate the mind through neuroregeneration, clearing the fog of depression while enhancing cognitive clarity and emotional resilience.

What It Helps With

PE-22-28 represents a breakthrough in neurological regeneration, offering targeted support for rapid mood enhancement and cognitive optimization:

  • Treatment-resistant depression that hasn’t responded to conventional therapies
  • Slow-onset antidepressant effectiveness and inadequate mood improvement
  • Cognitive decline and reduced mental clarity
  • Brain injury recovery and neurological trauma rehabilitation
  • Chronic stress-induced neural damage and emotional dysregulation
  • Learning and memory difficulties related to neuroplasticity deficits
  • Anxiety disorders with depressive components
  • Mood instability and emotional resilience challenges
  • Neurodegeneration concerns and age-related cognitive decline
  • Post-stroke depression and neurological recovery challenges

Mechanism of Action (The Science Behind It)

Let’s break down how PE-22-28 works as a neural catalyst through revolutionary BDNF-mimetic action. This specialized 7 amino acid peptide represents a breakthrough in neurological regeneration, functioning as a potent brain-derived neurotrophic factor mimetic that directly activates the same cellular pathways as BDNF without requiring complex receptor binding.

PE-22-28 works by directly activating TrkB receptors that normally respond to brain-derived neurotrophic factor, essentially tricking the brain into rapidly initiating growth and repair processes. This peptide mimics the most active region of BDNF, binding to receptors with even higher affinity than the native protein, triggering immediate downstream signaling cascades that promote neuronal survival, growth, and synapse formation.

What truly distinguishes PE-22-28 is its remarkable speed and efficiency in creating neurological changes. Unlike SSRI antidepressants that require weeks to show effect through gradual neurotransmitter adjustment, PE-22-28 generates observable improvements within hours by directly stimulating cellular growth factors. Through activation of CREB signaling and enhanced expression of synaptic proteins, the peptide essentially rewires depressed neural circuits while improving neuroplasticity for lasting cognitive adaptation.

Rather than merely masking symptoms, PE-22-28 rebuilds the neural architecture that supports mood and cognition, creating sustainable improvements that can persist beyond active treatment. This creates fundamental neurological restructuring that addresses the root cellular dysfunction underlying depression and cognitive decline.

Popular Use Cases

  • Treatment-Resistant Depression:
    Individuals who haven’t responded to multiple antidepressant trials seeking rapid, fundamental mood improvement.
  • Cognitive Enhancement:
    People pursuing enhanced learning capacity, memory formation, and cognitive flexibility through neuroplasticity optimization.
  • Neurological Recovery:
    Those recovering from traumatic brain injury, stroke, or other neurological trauma requiring accelerated healing.
  • High-Performance Cognitive Demands:
    Professionals and students seeking enhanced mental performance and cognitive resilience.
  • Chronic Stress Recovery:
    Individuals recovering from prolonged stress that has created structural brain changes and cognitive deficits.
  • Age-Related Cognitive Decline:
    People seeking to maintain or restore cognitive function through neuroregeneration.

Dosage + Duration

Subcutaneous Injection Protocol:

  • Treatment-Resistant Depression:
    200-500 mcg administered daily for 2-4 weeks
  • Cognitive Enhancement:
    100-300 mcg administered every other day for 4-6 weeks
  • Neurological Recovery:
    500-1000 mcg administered daily for 2-6 weeks (combined with rehabilitation)
  • Maintenance Cognitive Support:
    100-200 mcg administered 2-3 times weekly

Research Protocol Duration:

  • Initial Assessment:
    2-4 weeks to evaluate individual response patterns
  • Intensive Intervention:
    4-6 weeks for structural neurological changes
  • Maintenance Protocols:
    Periodic cycles based on neurological assessment

Strategic Timing:

  • Morning Administration:
    Often preferred for cognitive enhancement applications
  • Consistent Schedule:
    Same timing daily to optimize neurogenic patterns
  • Post-Treatment Monitoring:
    Extended observation periods due to lasting effects

Note: PE-22-28 has a serum half-life of 90-120 minutes, but neurological effects persist 12-24 hours due to sustained growth factor activation.

Side Effects

PE-22-28 demonstrates excellent safety in preclinical studies with minimal reported adverse effects:

  • No Significant Side Effects:
    Preclinical research shows excellent tolerability
  • Rare Initial Adjustment:
    Some subjects report mild fatigue during first days as brain adapts
  • Excellent Safety Profile:
    No observed toxicity at therapeutic doses in animal studies
  • Neurological Specificity:
    Targets brain tissue without affecting other organ systems
  • No Withdrawal Issues:
    Cessation doesn’t create dependency or rebound effects

The peptide’s outstanding safety profile stems from its specificity for TrkB receptors and natural BDNF-mimetic action.

Peptide Type

Classification: Neuropeptide/BDNF-Mimetic

PE-22-28 is a synthetic peptide fragment designed to mimic the most active region of brain-derived neurotrophic factor with enhanced stability and bioavailability.

Number of Amino Acids

7 amino acids – This heptapeptide contains the precise sequence derived from BDNF necessary for optimal TrkB receptor activation and neurogenic signaling.

FDA Status

Research compound only –

PE-22-28 is not FDA approved for any medical condition and remains in preclinical research phase with extensive safety and efficacy data in animal models.

Experience Level

Advanced – PE-22-28 requires expert guidance due to its:

  • Powerful neurological effects requiring careful monitoring
  • Research-only status necessitating institutional oversight
  • Need for comprehensive neurological assessment before and during use
  • Potential for profound structural brain changes requiring professional supervision

Popular Combinations (Stacks)

Neurological Recovery:

  • PE-22-28 + NAD+ (neurogenesis support + cellular energy for growth demands)
  • PE-22-28 + anti-inflammatory compounds (optimal healing environment)

Cognitive Enhancement:

  • PE-22-28 as standalone compound (most effective approach for neuroplasticity)
  • PE-22-28 + lifestyle neuroplasticity support (exercise, meditation, learning)

Depression Treatment:

  • PE-22-28 + Selank (structural rebuilding + anxiety management)
  • PE-22-28 + comprehensive mood support protocols

Note: PE-22-28 typically functions most effectively as a standalone compound due to its potent direct neurological effects.

nudaLabs Clinical Note

PE-22-28 represents a frontier approach in our research portfolio for clients seeking profound neurological transformation through direct neural regeneration. While currently limited to research applications, we carefully evaluate whether this powerful neuropeptide might be appropriate for individuals requiring rapid neurological intervention under expert supervision.

Research Biomarkers We Would Monitor:

  • Neuroplasticity indicators (BDNF levels, growth factor expression)
  • Cognitive function assessments (memory, processing speed, executive function)
  • Mood and depression rating scales (Hamilton, Beck Depression Inventory)
  • Neuroimaging markers (hippocampal volume, connectivity patterns)
  • Stress biomarkers (cortisol, inflammatory markers)
  • Safety parameters (comprehensive neurological assessment)

Research Insights: Based on preclinical data, the most promising PE-22-28 applications combine targeted neurological intervention with comprehensive brain health support. Subjects showing optimal responses pair PE-22-28 with lifestyle factors that support neurogenesis including exercise, stress management, and cognitive challenge.

Notable Research Pattern: Preclinical studies consistently show that subjects initially seeking rapid antidepressant effects discover unexpected improvements in cognitive function, learning capacity, and stress resilience. PE-22-28 appears to create comprehensive neurological optimization beyond its primary therapeutic targets.

Product Specifications & Quality Assurance

nudaLabs PE-22-28 (10mg) Vial Specifications:

Molecular Information:

  • CAS Number: Research compound (no assigned CAS number)
  • Molecular Weight: Approximately 800-900 Da (7 amino acid sequence)
  • Peptide Classification: BDNF-mimetic neuropeptide fragment
  • Research Grade: Preclinical research compound

Quality Standards:

  • Purity: ≥98% (verified by HPLC-MS)
  • Appearance: White to off-white lyophilized powder
  • Solubility: Readily soluble in sterile water or bacteriostatic water
  • Endotoxin Level: <1.0 EU/mg
  • Manufacturing: USA research facility under GMP conditions
  • Synthesis Method: Solid Phase Peptide Synthesis (SPPS)

Storage & Handling:

  • Storage Temperature: -20°C (freezer) before reconstitution
  • Shelf Life: 6-12 months when stored properly and protected from light
  • Reconstituted Storage: 2-8°C (refrigerator) for up to 7-14 days
  • Recommended Reconstitution: Bacteriostatic water at 0.5-1mg/mL concentration

Quality Control Testing: Every batch undergoes comprehensive analysis including:

  • High-Performance Liquid Chromatography (HPLC) for purity verification
  • Mass Spectrometry (MS) for molecular weight confirmation
  • Amino acid analysis for sequence verification
  • Endotoxin testing for safety assurance
  • Sterility testing for research applications
  • Stability testing under various storage conditions

Research Guidelines:

  • Institutional Oversight: Research use only under institutional review board approval
  • Expert Supervision: Requires experienced researchers familiar with neuropeptide protocols
  • Documentation: Comprehensive documentation required for research protocols
  • Safety Monitoring: Regular neurological assessment recommended

Compliance & Safety:

  • Research Use Only: This product is intended for laboratory and institutional research purposes only
  • Not for Human Consumption: Not approved for therapeutic, diagnostic, or human use outside research settings
  • FDA Status: Not approved by the FDA for any medical condition
  • IRB Approval: Institutional Review Board approval required for human research
  • Batch Tracking: Each vial includes unique lot numbers for full research traceability
  • Certificate of Analysis (COA): Available for each batch upon request

Important Research Notes:

  • Requires institutional oversight and expert supervision
  • Limited human safety data – comprehensive monitoring essential
  • Powerful neurological effects require careful dose escalation
  • Not recommended during pregnancy or breastfeeding

PE-22-28 represents the cutting edge of neurological regeneration research, offering unprecedented potential for rapid mood enhancement and cognitive optimization through direct BDNF-mimetic action.

As a research compound, it requires the highest standards of institutional oversight and expert supervision while offering remarkable possibilities for advancing our understanding of neuroplasticity and therapeutic neuroregeneration.

Are your peptides safe and lab-tested?

Yes. Every peptide we offer is sourced from FDA-registered compounding pharmacies or ISO-certified research laboratories that uphold the highest standards of purity, sterility, and identity verification. Each batch undergoes rigorous third-party testing for contaminants, potency, and peptide sequence accuracy. While peptides are not FDA approved for general medical use unless explicitly indicated, they are widely used under the regulatory classification of compounded or research compounds. At nudaLabs, we only work with vetted providers whose testing protocols and safety data meet or exceed regulatory expectations. Your safety is our baseline. Our protocols are built on trust, transparency, and clinically responsible use. This is the nuda way.

In some cases, yes. Some therapeutic peptides require a prescription and are dispensed through licensed compounding pharmacies. However, certain peptides are legally classified as “research-use only,” meaning they may be sold without a prescription depending on your jurisdiction and intended use. At nudaLabs, we guide you through this landscape with precision and integrity. Our process begins with the first clinically integrated AI tool for peptide protocol personalization (called the nudaVitae – include link here). It is designed to align your biology, goals, and safety profile with the peptides best for your body. We also offer optional telehealth consultations with peptide consultants to ensure medical appropriateness, compliance, and clarity. Whether your protocol involves prescription compounds or research peptides, our care team will walk with you every step of the way, prioritizing safety, legality, and personalized optimization.

<p>All peptides are shipped directly from licensed U.S. pharmacies or ISO-certified labs to our facility in Bentonville, Arkansas, and then to your door in secure, temperature-controlled packaging. If the peptide requires cold-chain integrity (such as lyophilized powders or reconstituted vials), your order will include cold packs or insulated materials to maintain stability during transit. Most peptides are stable at room temperature for short durations, but we recommend immediate refrigeration upon arrival. Shipping includes detailed instructions for storage, handling, and reconstitution (if applicable). For added protection, tracking numbers and insurance are included with every shipment. At this time, we do not ship outside the United States.</p>

All peptides are shipped directly from licensed U.S. pharmacies or ISO-certified labs to our facility in Bentonville, Arkansas, and then to your door in secure, temperature-controlled packaging. If the peptide requires cold-chain integrity (such as lyophilized powders or reconstituted vials), your order will include cold packs or insulated materials to maintain stability during transit. Most peptides are stable at room temperature for short durations, but we recommend immediate refrigeration upon arrival. Shipping includes detailed instructions for storage, handling, and reconstitution (if applicable). For added protection, tracking numbers and insurance are included with every shipment. At this time, we do not ship outside the United States.

That’s exactly why nudaLabs exists. Rather than guessing or buying blindly, we invite you to complete a short intake and schedule a clinical consult through our platform. From there, we create your personalized nudaVitae, an elegant, biologically aligned peptide protocol based on your health history, goals, labs, and lifestyle. Whether you’re new to peptides or refining an existing protocol, our team tailors every recommendation with precision. The right peptide isn’t just about symptoms; it’s about rhythm, recovery, and the deeper story your body is telling. We help you listen.

We welcome thoughtful, patient-centered providers into our clinical and compounding network. If you’re interested in offering nuda protocols to your patients or integrating our peptides into your practice, your first step is to fill out our Provider Partnership Application [insert link]. Once submitted, our medical team will schedule a discovery call to explore alignment, licensing, fulfillment logistics, and collaborative care models. We offer white-labeled protocols, access to nuda-branded education, and optional telehealth coverage if needed. At nudaLabs, we don’t just distribute peptides we are building an ecosystems of care around them (technology, education, consultation, and implementation).

Frequently Asked Question

Explore Our Peptides

GLP1-R Revolution (24mg)
GLP1-T Harmony (100 mg)
GLP1-T Harmony (60 mg)
KLOW (GHK-cu 50mg/BPC-157 10mg/TB500 10mg/KPV 10mg)